# OnCo record orphan-designation (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/orphan-designation/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "orphan-designation" ;
  schema:name "Orphan drug designation"@en ;
  schema:alternateName "orphan"@en, "orphan drug"@en, "orphan designation"@en, "orphan drug status"@en, "orphan status"@en, "orphan indication"@en, "Orphan Drug Act"@en, "orphan exclusivity"@en, "rare disease designation"@en, "rare paediatric disease designation"@en, "priority review voucher"@en, "priority review vouchers"@en ;
  schema:description "A status for drugs treating rare diseases (under 200,000 US patients, or under 5 in 10,000 in the EU) that gives the company tax credits, fee waivers and seven to ten years of market exclusivity, to make rare-disease drug development worthwhile."@en ;
  schema:url <https://onco.cc/terms/orphan-designation/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Orphan_drug> ;
  schema:citation <https://en.wikipedia.org/wiki/Orphan_drug> ;
  onco:related <https://onco.cc/terms/breakthrough-designation/>, <https://onco.cc/terms/fast-track-rmat/>, <https://onco.cc/terms/label-indication/>, <https://onco.cc/terms/orphan-drug-act/>, <https://onco.cc/terms/eu-orphan-regulation/>, <https://onco.cc/terms/inflation-reduction-act/>, <https://onco.cc/terms/us-regulatory-exclusivity/>, <https://onco.cc/terms/amnog/>, <https://onco.cc/terms/eu-pharma-package/>, <https://onco.cc/terms/bpca-prea/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/terms/rare-cancers/> .